Newsletter Subject

🎤 Joe Rogan’s Spoti-fiasco

From

robinhood.com

Email Address

noreply@robinhood.com

Sent On

Wed, Jan 26, 2022 11:36 AM

Email Preheader Text

…is getting Spotify into hot water with doctors over vaccine comments ? Spotify planting pods

…is getting Spotify into hot water with doctors (and Neil Young) over vaccine comments [Disclosures](   Spotify planting pods in its “Gated Garden” [Kjell Linder via Getty Images]   Yesterday’s Market Moves   Dow Jones 34,298 (-0.19%) S&P 500 4,357 (-1.22%) Nasdaq 13,539 (-2.28%) Bitcoin $36,811 (+0.30%) Dow Jones 34,298 (-0.19%) S&P 500 4,357 (-1.22%) Nasdaq 13,539 (-2.28%) Bitcoin $36,811 (+0.30%) Hey Snackers, RIP to the No. 2 pencil’s greatest foe: The SAT is officially going completely [digital]( starting in 2024. Future high schoolers will never know the anxiety induced by oval bubbles. Stocks closed lower yesterday after a tumultuous session, though major indexes rallied midday. [Pfizer]( [launched]( the first study testing an Omicron-specific vaccine on people, while the IMF [cut]( this year’s global growth forecast as recovery slows in the US and China. JRE Joe Rogan’s Spotify pod sparks backlash from doctors and Neil Young, as moderation takes center stage “The Joe Rogan Experience”... just got more complicated. JRE is the world's largest podcast, with an [estimated]( 11M listeners per episode. In 2020, [Spotify]( signed a deal to make the pod Spotify-exclusive for a reported $100M. Now, a viral December episode is drawing fresh criticism: - The guest: Rogan interviewed Dr. Robert Malone, a virologist who worked on early mRNA research. Malone is now a Covid vaccine critic, and was [Twitter]( for posting misinfo. - The episode: Malone promoted baseless conspiracy theories — from claiming hospitals have financial incentives to diagnose deaths as Covid-related to saying that getting vaxxed is riskier for people who've had Covid. - The backlash: 270 medical experts [signed]( a letter asking Spotify to curb misinfo on its platform, citing the Malone episode. On Monday, singer Neil Young [demanded]( that Spotify remove all his music — or remove JRE. I’m a pod-star, not a doctor... Rogan has [said]( he is not anti-vax, and that he encourages "many" people to get vaccinated, but this [isn't]( the first time he's been criticized for Covid misinfo. Spotify has removed thousands of episodes containing Covid misinfo in the past. It has also reportedly [removed]( 42 JRE episodes, including ones featuring far-right activists — but none related to vaccines. As its pod business booms, critics want clearer moderation policies. - $1B+: How much Spotify has splurged on pod-related purchases. Including: The Ringer and Parcast — plus, exclusives like “Call Her Daddy.” Targeted pod ads make up a growing share of Spotify’s [$2.5B]( quarterly revenue. - #1: In October, Spotify [overtook]( [Apple]( as the US's biggest pod platform, largely thanks to its "gated garden" strategy. THE TAKEAWAY With great publishing power comes great responsibility… The calls to action were broader than JRE — they were directed at Spotify’s moderation policies (or lack thereof). Unlike many large platforms, Spotify doesn't appear to have a defined misinformation policy, or at least one that’s consistently enforced. Yet moderation will likely become a growing issue for Spotify as its business grows — just as it is for other social and streaming giants. Pills Mark Cuban’s Cost Plus wants to make prescription drugs more affordable and transparent From “Shark Tank” to the aspirin aisle… Celeb investor Mark Cuban [launched]( an online pharmacy designed to lower prices of 100 generic drugs. The Cost Plus Drug Co. aims to simplify healthcare’s complex biz model by cutting out intermediaries and selling drugs for wholesale prices — plus a fixed 15% markup. - Drug prices are often shockingly high because of complex negotiations between drugmakers, pharmacies, and health insurers. - CP buys drugs wholesale and breaks down their costs on its website. Think: ingredients = $12, manufacturing = $3, profit = $2.10. Thirty pills of a life-saving drug could cost $2.5K at [CVS]( — but $17 at CP. - CP doesn’t accept insurance, but it could be a huge help for the 31M Americans without insurance. Rattling big pill bottles… Nearly 80% of US prescriptions are managed by CVS, [Cigna]( and [UnitedHealth](. Critics [say]( pharmacy heavyweights use complex clauses to drive up prices, and regulators are investigating the industry. Several companies are trying to fix healthcare’s pricing problem: - Large employers like [Walmart]( [Boeing]( [Apple]( and [Microsoft]( formed a healthcare group last year to ditch big pharmacies and save money. - Health startups including Capsule, Roman, [Hims & Hers]( and [GoodRx]( also offer transparent drug marketplaces that challenge traditional pharmacies. THE TAKEAWAY Price matters, but so does transparency… That’s why companies are pursuing more transparent alternatives to traditional pharma. Cost Plus can’t fully replace pharmacy behemoths (it only sells generic drugs) and its prices may not be lower than competitors’. But CP is building a Texas factory to make its own meds. And if it steals sales from juggernauts like CVS, it could help push the whole industry to become more transparent. What else we're Snackin' - [Cream]( [Unilever]( which makes everything from Dove soap to Ben & Jerry’s, said it would split into five divisions (like: beauty, ice cream) to boost sales and cut costs — and slash 1.5K jobs. - [Green]( To reach global net-zero emissions by 2050, the world will have to spend $9.5T annually on low-carbon infrastructure, according to McKinsey — that’s $3.5T more than what’s currently spent. - [Rev]( [GM]( said it would invest $7B in Michigan factories to pump out EVs like electric pickups and hire 4K new workers in the Great Lakes State. - [Chipped]( [Nvidia]( shares fell nearly 5% after Bloomberg reported the chip maker could ditch its $40B purchase of British chip designer Arm over antitrust pressure. Nvidia could lose its $1.25B deposit. - [Cloudy]( [Microsoft]( stock slipped nearly 5% despite reporting a 20% jump in sales and profits, beating expectations. Investors were bummed that cloud-computing sales slowed. 🍪 Thanks for Snacking with us! Want to share the Snacks? Invite your friends to sign up [here](. The Snacks Daily Podcast You’ll find strawberries on aisle six — of the ninth floor. Vertical veggie-farming startup Plenty just raised $400M from Walmart and others as demand for sky-grown lettuce grows. [Tune in]( to hear why America’s biggest grocer believes vertical farming is going to take off. Snack Fact Of the Day [95% of workers want to set their own hours, while 78% want location flexibility]( Wednesday - Fed monetary policy meeting - Earnings expected from: Tesla, Abbott Labs, Intel, AT&T, Boeing, Anthem, and Levi Strauss Authors of this Snacks own shares of: GM, Pfizer, Apple, Amazon, Microsoft, Walmart, CVS, Nvidia, Spotify, and Tesla ID: 2008065 Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC (Member [SIPC]( and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are for informational purposes only, and are not a recommendation of an investment strategy or to buy or sell any security, digital asset (cryptocurrency, etc) in any account. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk including the loss of principal and past performance does not guarantee future results. [Robinhood Terms and Conditions]( • [Disclosure Library]( • [Our Editorial Principles]( • [Contact Us]( • [FAQ]( [Manage Your Subscription Preferences](

Marketing emails from robinhood.com

View More
Sent On

05/12/2024

Sent On

08/11/2024

Sent On

29/10/2024

Sent On

22/10/2024

Sent On

21/10/2024

Sent On

18/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.